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Challenges for Implementing a 
PTSD Preventive Genomic 
Sequencing Program in the U.S. 
Military 
Gabriel Lázaro-Muñoz1 & Eric T. Juengst23 
There is growing interest in using the quickly developing 
field of genomics to contribute to military readiness and 
effectiveness. Specifically, influential military advisory panels 
have recommended that the U.S. military apply genomics to help 
treat, prevent, or minimize the risk for post-traumatic stress 
disorder (PTSD) among service members. This article highlights 
some important scientific, legal, and ethical challenges regarding 
the development and deployment of a preventive genomic 
sequencing (PGS) program to predict the risk of PTSD among 
military service members. 
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I. Introduction 
Technological superiority is an essential aspect of military 
readiness and effectiveness. To achieve this, the United States 
Department of Defense (DoD) invests approximately $70 billion each 
year in research, development, test, and evaluation programs.4 These 
investments advance technologies that range from precision strike 
weapons and unmanned vehicles to environmental quality and 
medical technologies.5  There is growing interest in using the quickly 
developing field of genomics to contribute to military readiness and 
effectiveness.6 Specifically, influential military advisory panels have 
 
4. U.S. DEF. DEP’T, DEPARTMENT OF DEFENSE BUDGET FISCAL 2014: 
RESEARCH, DEVELOPMENT, TEST & EVALUATION (RDT&E) PROGRAMS 
(R-1) 3 (Apr. 2013), http://comptroller.defense.gov/Portals/ 
45/Documents/defbudget/fy2014/fy2014_r1.pdf [hereinafter DoD 
RDT&E]. 
5. Id. at N-5, A-6, N-12, A-3, D-48. 
6. JASON, THE $100 GENOME: IMPLICATIONS FOR THE DOD 1 (2010) 
[hereinafter, JASON Report]; PATRICK LIN, MAXWELL J. MEHLMAN & 
KEITH ABNEY, ENHANCED WARFIGHTERS: RISK, ETHICS, AND POLICY 2 
(2014).  
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recommended that the U.S. military apply genomics to help treat, 
prevent, or minimize the risk for post-traumatic stress disorder 
(PTSD) among service members.7 This article highlights some 
important scientific, legal, and ethical challenges regarding the 
development and deployment of a preventive genomic sequencing 
(PGS) program to predict the risk of PTSD among military service 
members. 
The field of genomics examines the informational content and 
functional dynamics of the genes that make up the human genome. 
An important endeavor in genomics is the identification of genetic 
variants indicating that an individual is at an increased risk of 
developing a poor health outcome, such as different types of cancer, 
heart disease, diabetes, and mental health disorders. Recently, the 
development of massively parallel DNA-sequencing technologies 
(MPS) has fueled progress in genomics by allowing the sequencing of 
numerous genes at a time and decreasing the cost of sequencing an 
individual’s genome.8 MPS has made whole genome- and whole 
exome-sequencing (WGS/WES) more accessible to researchers and 
clinicians, which is quickly expanding the medical community’s 
understanding of the genetics of certain diseases and the potential 
applications of genomic technologies to both the civilian and military 
contexts.  
DoD has long demonstrated an interest in implementing genetic 
technologies in the military. To date, DoD has implemented a 
successful DNA registry for identifying human remains, and routinely 
screens service men and women for genetic conditions such as sickle 
cell anemia and Glucose-6-Phosphate Dehydrogenase (G6PD) 
deficiency.9 The recent surge in WGS/WES research has further 
increased DoD’s interest in applying genomic technologies to the 
 
7. See JASON Report, supra note 3, at 43; Million Veteran Program 
(MVP), U.S. DEP’T VET. AFF. (Mar. 25, 2015), http://www.research.va. 
gov/MVP/. 
8. DNA Sequencing Costs: Data from the NHGRI Genome Sequencing 
Program (GSP), NAT’L HUM. GENOME RES. INST. (Oct. 31, 2014), 
http://www.genome.gov/sequencingcosts/; E.D. Green & M.S. Guyer. 
Charting a Course for Genomic Medicine from Base Pairs to Bedside, 
470 NATURE 204, 205 (2011); see Tom Walsh et al., Detection of 
inherited mutations for breast and ovarian cancer using genomic 
capture and massively parallel sequencing, 107 PROC. NAT’L ACAD. SCIS. 
12629, 12629–30 (2010). 
9. Hemoglobin S and Erythrocyte Glucose-6-Phosphate Dehydrogenase 
Deficiency Testing Program, DoD Instruction 6465.1 (Jul. 29, 1981); 
Susannah Baruch & Kathy Hudson, Civilian and Military Genetics: 
Nondiscrimination Policy in a Post-GINA World, 83 AM. J. HUM. 
GENETICS 435, 439 (2008); Mark Nunes, GenePOPS—Genes in 
Uniform: Don’t Test, Don’t Tell, GENETICS & PUB. POL’Y CTR. (Jan. 10, 
2006) http://www.dnapolicy.org/video/genepops/011006/index.htm. 
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military context. In 2010, the JASON Defense Advisory Panel 
released a report on the opportunities and challenges of WGS/WES 
technologies for the military.10 The JASON report’s major 
recommendation was a call to action: 
The DoD should establish policies that result in the collection of 
genotype and phenotype data, the application of bioinformatics 
tools to support the health and effectiveness of military 
personnel, and the resolution of ethical and social issues that 
arise from these activities. The DoD and the VA should affiliate 
with or stand up a genotype/phenotype analysis program that 
addresses their respective needs. Waiting even two years to 
initiate this process may place them unrecoverably behind in 
the race for personal genomics information and applications. 11 
PTSD was one of the few phenotypes specifically identified by the 
JASON report, which could be of benefit to DoD because it “might 
reasonably be expected to have a genetic component [and] have 
special relevance to military performance and medical cost 
containment.”12 Nevertheless, the use of PTSD genomics in the 
military raises a number of questions that must be addressed to avoid 
extemporaneous applications of genomic technologies that do not 
sufficiently maximize the benefits and minimize the harms of using 
these technologies.13  
An examination of the challenges of implementing a PTSD-PGS 
program in the military was beyond the scope of the JASON report. 
This article aims to examine some of the important issues to consider 
when evaluating the potential use of genomics to identify risk for 
PTSD in the military and making decisions based on this information. 
Part II of this article provides a clinical overview of PTSD and 
examines PTSD as a problem for service members and the military, 
Part III examines some of the scientific challenges of establishing a 
PTSD-PGS program and presents the current state of psychiatric and 
PTSD genomics. Part IV considers some of the legal challenges 
regarding the potential implementation of a PTSD-PGS in the 
military, and Part V considers some of the important ethical 
questions involved. 
 
10. JASON Report, supra note 3, at 1.  
11. Id. at 50.  
12. Id. at 43. 
13. See generally B.S. Wilfond & K. Nolan, National Policy Development for 
the Clinical Application of Genetic Diagnostic Technologies: Lessons 
from Cystic Fibrosis, 270 JAMA 2948 (1993) (describing issues linked 
with the use of an extemporaneous model for health policy development 
and arguing in favor of an evidentiary model). 
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II. PTSD as Problem for Service Members and the 
Military 
PTSD can be triggered by exposure to actual or threatened death, 
serious injury, or sexual violation.14 However, PTSD is not just any 
stress or aversive memory related to an actual or threatened 
traumatic event. PTSD is a trauma- or stress-related disorder with 
specific symptoms that must be present for at least one month.15 A 
PTSD diagnosis requires the presence of one or two symptoms from 
each of the following symptom groups: Re-experiencing (e.g. 
flashbacks, spontaneous memories or recurrent dreams of the 
traumatic event); Avoidance (e.g. when an individual tries to avoid 
trauma-related thoughts, feelings or external reminders of the event); 
Negative cognitions and mood (e.g. persistent and distorted sense of 
blame of self or others, persistent inability to experience positive 
emotions, inability to remember key aspects of the traumatic event); 
and Arousal (e.g. aggressive, self-destructive or reckless behavior, 
exaggerated startle response, hypervigilance, problems with 
concentration, and sleep disturbances).16  
The lifetime prevalence of PTSD in the U.S. general population is 
estimated at 6.8%.17 However, the prevalence among service members 
is generally higher; for example, researchers estimate that 10% of Gulf 
War veterans18 and 13.8% of Operation Enduring Freedom and 
Operation Iraqi Freedom veterans experience PTSD.19 As one might 
 
14. National Center for PTSD: DSM-5 Criteria for PTSD, U.S. DEP’T VET. 
AFF. (Jan. 3, 2014), http://www.ptsd.va.gov/professional/PTSD-
overview/dsm5_criteria_ptsd.asp; AM. PSY. ASS’N, POSTTRAUMATIC 
STRESS DISORDER: DSM-5 CHANGES IN PTSD CRITERIA 1 (2013), 
http://www.psychiatry.org/File%20Library/Practice/DSM/DSM-
5/DSM-5-PTSD.pdf. 
15. See DSM-5 Criteria for PTSD, supra note 11.  
16. Id. 
17. Ronald C. Kessler et al., Lifetime Prevalence and Age-of-Onset 
Distributions of DSM-IV Disorders in the National Comorbidity Survey 
Replication, 62 ARCHIVES GEN’L PSYCHIATRY 593, 596 (2005). 
18. Han Kang et al., Post-Traumatic Stress Disorder and Chronic Fatigue 
Syndrome-like illness among Gulf War Veterans: A population-based 
survey of 30,000 Veterans, 157 AM. J. EPIDEMIOL. 141, 145 (2003). 
19. RAND, INVISIBLE WOUNDS OF WAR: PSYCHOLOGICAL AND COGNITIVE 
INJURIES, THEIR CONSEQUENCES, AND SERVICES TO ASSIST RECOVERY 97 
(Terry Tanielian & Lisa Jaycox eds., 2008) [hereinafter INVISIBLE 
WOUNDS REPORT]; see generally INST. MED. NAT’L ACADS., TREATMENT 
FOR POSTTRAUMATIC STRESS DISORDER IN MILITARY AND VETERAN 
POPULATIONS: INITIAL ASSESSMENT (2012) (stating that the percentage of 
veterans that served in Afghanistan and Iraq that suffer from PTDS is 
between 13% and 20%). 
Case Western Reserve Journal of International Law 47 (2015) 
Challenges for Implementing a PTSD 
92 
expect, the incidence of PTSD among service members is closely 
associated to traumatic events experienced during combat exposure.20 
Therefore, due to the nature of their jobs, service members are 
particularly at risk of being impacted by PTSD. In fact, PTSD was 
the third-most common disability for veterans receiving compensation 
in fiscal year 2012, after tinnitus and hearing loss.21  
The economic cost of mental health services is another aspect of 
the burden of PTSD and other mental health disorders. The 
estimated two-year cost of PTSD and major depression for 1.6 million 
service members returning home from Afghanistan and Iraq is 
between $4.0 billion and $6.2 billion, depending on whether that 
statistic includes the value of lives lost to suicide mortality.22 
Furthermore, the number of veterans needing mental health services 
increased from 927,052 to 1.46 million over the last eight years, which 
led the Department of Veterans Affairs (VA) to increase its mental 
health care budget 39% from 2009 to 2013.23  
PTSD symptoms not only lead to a large degree of suffering for 
service members, but it also leads to suffering and difficulty for their 
families.24 In particular, PTSD often leads to impairments in 
occupational functioning, which can limit service members’ 
effectiveness on the job and force them to take time off work for 
treatment.25 One concern among some military leaders is that PTSD 
 
20. Tyler C. Smith et al., New Onset and Persistent Symptoms of Post-
Traumatic Stress Disorder Self Reported After Deployment and Combat 
Exposures: Prospective Population Based US Military Cohort Study, 336 
BRIT. MED. J 366, 366 (2008); see Naomi Breslau, The Epidemiology of 
Trauma, PTSD, and Other Postrauma Disorders, 10 TRAUMA, VIOL. & 
ABUSE 198, 203 (2009).  
21. Richard J. McNally & B. Christopher Frueh, Why are Iraq and 
Afghanistan War Veterans Seeking PTSD Disability Compensation at 
Unprecedented Rates?, 27 J. ANXIETY DISORDS. 520, 520–21 (2013). 
22. INVISIBLE WOUNDS REPORT, supra note 15, at 200.  
23. U.S. DEP’T VET. AFF., 2013 PERFORMANCE AND ACCOUNTABILITY 
REPORT I-2 (2013), http://www.va.gov/budget/report/ [hereinafter VA 
P&A 2013 Report]. 
24. Lisa Gorman et al., National Guard Families After Combat: Mental 
Health, Use of Mental Health Services, and Perceived Treatment 
Barriers, 62 PSYCHIATRIC SERVS. 28, 31 (2011); Abigail H. Gewirtz et 
al., Posttraumatic Stress Symptoms Among National Guard Soldiers 
Deployed to Iraq: Associations With Parenting Behaviors and Couple 
Adjustment, 78 J. CONSULT. & CLIN. PSYCHOL. 599, 603 (2010); see 
Suzannah K. Creech et al., Impact of Coping Style and PTSD on Family 
Functioning After Deployment in Operation Desert Shield/Storm 
Returnees, 26 J. TRAUM. STRESS 507, 507 (2013).  
25. Paula P. Schnurr & Carole A. Lunney, Work-Related Outcomes Among 
Female Veterans and Service Members After Treatment of 
Posttraumatic Stress Disorder, 63 PSYCHIATRIC SERVS. 1072, 1077–78 
(2012); David A. Adler et al., Psychiatric Status and Work Performance 
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can affect military readiness and effectiveness by decreasing available 
manpower and military duty performance.26 These issues, combined 
with the economic cost of PTSD, make PTSD prevention an 
important undertaking for DoD. A potential way to prevent or 
minimize the economic and biopsychosocial burden of PTSD in the 
military is to identify those service members who are at high genomic 
risk for developing PTSD and assign them to missions that will 
minimize their combat exposure or develop interventions that may 
help to decrease their chances of developing PTSD. When considering 
this possibility, one of the first steps should be to examine whether 
genome-based PTSD risk prediction is currently possible, and if not, 
to identify the scientific questions that remain to be answered before 
that goal can be realized.  
III. Scientific Challenges for PTSD Preventive 
Genomic Sequencing 
PTSD is a significant problem for the military, and in theory, 
genomics holds much promise for improving PTSD risk prediction.27 
However, in order to use genomics for PTSD risk prediction and make 
important personnel decisions based on this information, the military 
needs a solid scientific foundation that will allow it to reliably predict 
these risks. Recent developments in genomic technologies and 
psychiatric genomics research may eventually provide the military the 
genomic intelligence necessary to more reliably predict the risk of 
PTSD among service members. But, the field of psychiatric genomics 
cannot currently provide this robust scientific foundation, and it will 
probably not be able to do this for a number of years.  
A. Psychiatric Genomics 
To understand why reliable PTSD risk prediction based on 
genomics is not currently possible, and may not be for some time, we 
need to briefly examine the recent development and current state of 
psychiatric genomics. Uncovering the genomics of psychiatric 
disorders such as PTSD has proven to be a challenge.28 Psychiatric 
 
of Veterans of Operations Enduring Freedom and Iraqi Freedom, 62 
PSYCHIATRIC SERVS. 39, 40 (2011).  
26. See Michael P. Fisher, PTSD in the U.S. Military, and the Politics of 
Prevalence, 115 SOC. SCI. & MED. 1, 5 (2014). 
27. See Nadia Solovieff et al., Genetic Association Analysis of 300 Genes 
Identifies a Risk Haplotype in SLC18A2 for Post-traumatic Stress 
Disorder in Two Independent Samples, 39 NEUROPSYCHOPHARM. 1872, 
1876 (2014). 
28. See generally Steven A. McCarroll et al., Genome-Scale Neurogenetics: 
Methodology and Meaning, 17 NAT. NEUROSCI. 756, 761 (2014) 
(concluding that while finding genomic markers for psychiatric disorders 
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disorders are complex diseases in which numerous genes and 
environmental factors play a role. In fact, even though the 
contribution of genomics is substantial,29 environmental factors, such 
as exposure to stress or traumatic events, are believed to play a more 
prominent role in determining the risk for psychiatric disorders.30  
Part of the difficulty in uncovering the genomics of psychiatric 
disorders stems from the fact that numerous genes are involved and 
each of these genes contributes only a small amount to the overall risk 
of developing a psychiatric disorder.31 In addition, individuals can 
have different combinations of genes that put them at risk, and these 
genes interact with other genes and environmental factors to shape 
overall risk.32 The small contribution of individual genes to the overall 
risk of developing a psychiatric disorder means that researchers need 
to examine very large samples of subjects with psychiatric disorders. 
Then, they need to compare their genetic profiles to carefully selected 
controls in order to obtain the statistical power necessary to detect 
the contribution of these genes (hereafter referred to as the “statistical 
power” problem).33  
As a further complication, there are more than 20,000 protein-
coding genes in the genome. Thus, in the pursuit of genes that are 
associated with psychiatric disorders, researchers face a challenging 
needle-in-a-haystack problem as well. For years, researchers tried to 
formulate informed hypotheses about which genes could contribute to 
the overall risk for a psychiatric disorder in order to focus their 
research on those genes that they believed were more likely to play a 
 
has progressed since 2009, when a more complete human genome was 
finally mapped, this is still in a nascent stage); see Stephen B. Manuck 
& Jeanne M. McCaffery, Gene-Environment Interaction, 65 ANN. REV. 
PSY. 41, 61 (2014); see Karestan Koenen et al., From Candidate Gene 
to Genome-wide Association: The Challenges and Promise of 
Posttraumatic Stress Disorder Genetic Studies, 74 BIOL. PSYCHIATRY 
634, 635 (2013).  
29. See Patrick F. Sullivan et al., Genetic Architectures of Psychiatric 
Disorders: The Emerging Picture and its Implications, 13 NAT. REVS. 
GEN. 537, 538 (2012); see Roger K. Pitman et al., Biological Studies of 
Post-Traumatic Stress Disorder, 13 NAT. REVS. NEUROSCI. 769, 777 
(2012).  
30. Teri A. Manolio, Bringing Genome-Wide Association Findings Into 
Clinical Use, 14 NAT. REVS. GEN. 549, 551 (2013). 
31. See id.; see McCarroll et al., supra note 25, at 761; see Manuck & 
McCaffery, supra note 25, at 42. 
32. See Manuck & McCaffrey, supra note 25, at 42.  
33. Aiden Corvin et al., Genome-Wide Association Studies: A Primer, 40 
PSYCHOL. MED. 1063, 1070–72 (2010).  
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role.34 Unfortunately, this candidate gene approach has proven 
inefficient and generated numerous inconsistent and contradictory 
findings.35  
B. How are Psychiatric Genomics Addressing these Challenges?  
In recent years, researchers have begun to perform large-scale 
genome-wide association studies (GWAS) to address the statistical 
power and needle-in-a-haystack problems.36 GWAS studies address 
the needle-in-a-haystack problem because, unlike candidate gene 
studies, they follow a hypothesis-free approach by examining large 
numbers of genes without an a priori determination of which genes 
might have any predictive value for psychiatric disorders. 37 
Even though GWAS help address the needle-in-a-haystack 
problem, this approach involves a great number of statistical tests,38 
which exacerbate the statistical power problem in psychiatric 
genomics. This means that GWAS for psychiatric disorders require 
even larger samples than candidate gene studies. Therefore, in order 
for GWAS to detect the many genes that make a small but significant 
contribution to the overall risk for psychiatric disorders, GWAS need 
samples that can be in the order of thousands of case and control 
subjects—perhaps even into the tens or hundreds of thousands.39 
Conducting these large-scale GWAS involves a great amount of 
resources and coordination that single research projects are often 
unable to achieve and therefore progress in psychiatric genomics can 
be slow.  
In recent years, psychiatric genomics researchers have begun 
developing conglomerates, such as the Psychiatric Genomics 
Consortium in order to pool resources and datasets.40 This approach 
 
34. See Koenen et al., supra note 25, at 634–35; see McCarroll et al., supra 
note 25, at 756–57; see Pitman et al., supra note 26, at 769-70. 
35. See Pitman et al., supra note 26, at 777; Marylin C. Cornelis et al., 
Genetics of Post-Traumatic Stress Disorder: Review and 
Recommendations for Genome-Wide Association Studies, 12 CURR. 
PSYCHIATRY REPS. 313, 314 (2010). 
36. Corvin et al., supra note 30, at 1063; Anna C. Need & David B. 
Goldstein, Schizophrenia Genetics Comes of Age, 83 NEURON 760, 760–
61 (2014). 
37. See Corvin et al., supra note 30, at 1072. 
38. Id. at 1071. 
39. See id.; see Koenen et al., supra note 25, at 634; Schizophrenia Working 
Grp. Psy. Genomics Consortium, Biological Insights from 108 
Schizophrenia-Associated Genetic Loci, 511 NATURE 421, 421 (2014) 
[hereinafter PGC Schizophrenia Nature 2014]. 
40. Psychiatric Genomics Consortium, UNIV. N. CAR. SCH. MED. (2014), 
http://www.med.unc.edu/pgc. 
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has allowed researchers to combine sets of GWAS data in order to 
conduct mega-analyses for a number of psychiatric disorders.41 The 
result of this large-scale GWAS and GWAS mega-analyses approach 
has been unprecedented advances in uncovering some of the genetic 
bases of schizophrenia42 and to a lesser extent bipolar disorder, major 
depressive disorder, attention deficit hyperactivity disorder, and 
autism.43 They have also identified a number of genes that play a role 
across numerous psychiatric disorders.44 However, these large-scale 
GWAS and mega-analyses approaches have not yet been applied to 
PTSD genomics. 
C. What about PTSD Genomics? 
Genomic influences account for 30%45 to 70%46 of the risk for 
PTSD, but PTSD genomics research has confronted the same 
statistical power and needle-in-a-haystack problems described above 
for research with other psychiatric disorders, together with a number 
of other complications particular to PTSD.47 For example, PTSD 
studies are not consistent in the way they define cases of PTSD or the 
characteristics of the control groups, some researchers use trauma-
exposed controls while others do not.48  
To date, PTSD genomics research has relied mostly on candidate 
gene studies.49 Although these studies have identified more than 
twenty genes associated with PTSD such as SLC6A4 (also known as 
5HTTLPR), DRD2, FKBP5, and PACAP, many consider these 
findings suspect because of how difficult it has been to replicate 
 
41. Sullivan et al., supra note 26, at 543. 
42. See Need & Goldstein, supra note 33, at 762; PGC Schizophrenia 
Nature 2014 supra note 36, at 424. 
43. See Psychiatric Genomics Consortium: Results, UNIV. N. CAR. SCH. 
MED. (2014), http://www.med.unc.edu/pgc/results. 
44. Cross-Disorder Grp. Psy. Genomics Consortium, Identification of Risk 
Loci with Shared Effects on Five Major Psychiatric Disorders: A 
Genome-Wide Analysis, 381 LANCET 1371, 1375–78 (2013). 
45. Murray B. Stein et al., Genetic and Environmental Influences on 
Trauma Exposure and Posttraumatic Stress Disorder Symptoms: A 
Twin Study, 159 AM. J. PSY. 1675, 1675 (2002). 
46. Carolyn E. Sartor et al., Common Genetic and Environmental 
Contributions to Post-Traumatic Stress Disorder and Alcohol 
Dependence in Young Women, 41 PSYCHOL. MED. 1497, 1502–03 (2011). 
47. See Solovieff et al, supra note 24, at 1876–77; see Koenen et al, supra 
note 25, at 635–36; see Pitman et al, supra note 26, at 780, 783; see 
Cornelis et al., supra note 32, at 323. 
48. See Solovieff et al., supra note 24, at 1873.  
49. See Stein, supra note 42, at 1675.  
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candidate gene PTSD studies.50 In contrast, large-scale GWAS and 
GWAS mega-analyses studies of schizophrenia have identified more 
than 350 genes that are reliably implicated in schizophrenia.51 Some 
PTSD GWAS studies have begun to emerge in the literature.52 These 
studies have identified some new genes and provided evidence for the 
association of others that had been reported in candidate gene 
studies.53 However, PTSD GWAS studies have used relatively small 
samples, which as recognized by the authors of these studies is a 
limitation that needs to be addressed in order to advance the field of 
PTSD genomics.54 
Fortunately, efforts are underway by prominent researchers to 
develop large-scale GWAS and mega-analyses for PTSD within the 
Psychiatric Genomics Consortium. 55 These efforts should help speed 
the process of uncovering the genomics of PTSD and these are not the 
only ongoing large-scale efforts. The VA is currently taking advantage 
of developments in MPS technologies, which have decreased the cost 
of WES, to help lead the charge towards uncovering the genomics of 
PTSD. In 2011, the VA launched the Million Veteran Program 
(MVP) “a ground-breaking genomic medicine program, [which] 
endeavors to collect genetic samples and general health information 
from 1 million Veterans in the next 5-7 years.”56 MVP’s goal is “to 
study how genes affect health…[d]ata collected from MVP will be 
stored anonymously for research on diseases like diabetes and cancer, 
and military-related illnesses, such as post-traumatic stress 
disorder.”57 As of September 30, 2013 more than 200,000 veterans 
have enrolled in MVP and the project has begun sequencing of the 
first samples.58  
 
50. Id. 
51. See Need & Goldstein, supra note 33, at 761.  
52. See Solovieff et al., supra note 24, at 1877; Pingxing Xie et al., Genome-
Wide Association Study Identifies Susceptibility Loci for Posttraumatic 
Stress Disorder, 74 BIOL. PSYCHIATRY 656, 661 (2013); see Guia 
Guffanti et al., Genome-Wide Association Study Implicates a Novel 
RNA Gene, the lincRNA AC068718.1, as a Risk Factor for Post-
Traumatic Stress Disorder in Women, 38 
PSYCHONEUROENDOCRINOLOGY  3029, 3030 (2013). 
53. See Solovieff et al., supra note 24, at 1877.  
54. See id.; Xie et al., supra note 49, at 661; see Guffanti et al., supra note 
49, at 3036. 
55. See Koenen et al., supra note 25, at 634. 
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While the identification of genomic variants that reliably predict 
high risk for PTSD or the integration of genomic information into risk 
prediction models for PTSD is probably a few years away, efforts such 
as the Psychiatric Genomics Consortium’s PTSD Working Group, 
and the VA’s MVP, are helping pave the way. Furthermore, given 
that the prospect of implementing a PTSD-PGS program in the 
military is currently being considered, it is important to begin 
examining some of the most relevant legal and ethical challenges these 
programs may generate. The following sections examine these issues. 
IV. Legal Challenges for implementing a PTSD-PGS 
Program in the Military 
Many of the legal and ethical considerations in establishing a 
PTSD-PGS program are dependent on the way such program would 
be implemented and how the military would use the information 
collected. To discuss this, one should assume, with the JASON 
report,59 that: such a program would employ DNA sequencing 
technologies such as MPS at the whole genome or whole exome (WGS 
or WES) levels; that participation in the program would be a 
requirement for all service members; and that the resulting genomic 
information about PTSD risks would be used for determining service 
assignments for military personnel. Each of these initial assumptions 
bears explanation before proceeding.  
We assume that a PTSD-PGS program in the military would 
employ WGS or WES, instead of more limited targeted sequencing, 
because of the number of genes the military would need to examine to 
offer useful predictions and the range of phenotypes that the military 
would be interested in examining.60 For example, given that PTSD is 
a complex disorder, predicting the risk of PTSD is likely to involve 
sequencing a large number of genes in different regions of the genome. 
Furthermore, in addition to PTSD, the JASON Report suggests that 
the military would be interested in a wide range of other phenotypes 
that would be relevant for military duty such as “the ability to 
tolerate conditions of sleep deprivation, dehydration, or prolonged 
exposure to heat, cold, or high altitude, or the susceptibility to 
traumatic bone fracture, prolonged bleeding, or slow wound 
healing.”61 Although panels of specific genes implicated in PTSD and 
all of these phenotypes could be created for targeted sequencing, on a 
mass scale, it will be much more cost efficient to sequence entire 
 
59. JASON Report, supra note 3, at 4 (recommending that the DoD 
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complete human genome sequence data from all military personnel.”). 
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genomes or exomes at once, even if the resulting data is only queried 
for PTSD risk variants.  
Second, we assume that a PTSD-PGS would be a requirement for 
all service members because, as with a universal vaccination scheme, 
an overcompensation strategy would likely be the most effective 
method for minimizing the risk of PTSD. Identifying high risk 
personnel that could face environments where there is a high 
likelihood of experiencing traumatic events would be useful, and it 
would be relatively harmless to discover that personnel in low stress 
environments are at low genomic risk for PTSD.  
Finally, in the absence of effective biomedical prophylaxis or 
treatment for PTSD, one of the principal reasons for establishing a 
PGS program would be to use genomic information to make service 
assignments by determining which service members are most likely to 
succeed in a particular mission and less likely to suffer harms such as 
PTSD.62 The military already uses information about genetic 
conditions such as sickle cell and G6PD deficiency to determine 
assignments so a PTSD-PGS program would likely be used to extend 
this practice.63  
The most serious legal concerns raised by a PTSD-PGS program 
are issues related to genetic discrimination and invasion of privacy. 
We will first examine the concerns about genetic discrimination. 
While the goal of using genomics to minimize the risk of PTSD may 
be noble, achieving this goal may involve discriminating against 
asymptomatic service members on the basis of their genomic 
information. For example, if the PTSD-PGS identified Private 
Williams as being at high risk for developing PTSD, his superiors 
could decide to assign him to duties where he would not be exposed 
to combat or to missions in which combat exposure was expected to 
be low. While this would likely minimize Private Williams’ risk of 
developing PTSD, it would also negatively impact his prospects of 
getting promotions. This may be particularly difficult to accept for 
Private Williams, and others like him, because they would be denied 
certain opportunities based on genomic risks that may never 
materialize, and not the presence of actual symptoms that limit their 
capacity to perform their job.  
In the civilian context, of course, the Genetic Information 
Nondiscrimination Act of 2008 (“GINA”) prohibits employers from 
using genomic information to assign employees to certain jobs.64 In 
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fact, GINA prohibits employers from even requesting that employees 
undergo any kind of genetic testing or that they disclose the results of 
genetic tests.65 However, GINA does not apply to the United States 
military. 66  Therefore, if the military implemented a PTSD-PGS 
program, service members like Private Williams would not be able to 
assert the protections afforded to civilians under GINA. Nevertheless, 
Private Williams may be able to argue that this practice violates the 
Constitution, by appealing to the Equal Protection clause.  
A. Equal Protection 
Service members who are denied certain assignments based on 
their genomic information could claim that these genome-based 
decisions constitute genetic discrimination that violates the equal 
protection principles found in the due process clause of the Fifth 
Amendment.67 Service members could claim, for example, that the 
program has a discriminative motive, that of either identifying and 
terminating service members with supposedly inferior genomes from 
service, or denying them certain opportunities. If the information 
generated by the program is used to determine assignments, service 
members could also claim that the application of the program 
discriminates against service members who are physically and 
emotionally fit for assignments, but have some genomic variants that 
indicate that in the future they might develop certain conditions such 
as PTSD. In that sense, the program would treat similarly situated 
individuals (at least in terms of phenotype) differently based solely on 
their genomic profiles. Finally, service members could argue that there 
is no justification or rational basis for denying them certain 
opportunities because they currently have no symptoms, and the 
genetic contribution to the risk of complex diseases like PTSD is 
relatively small compared to the contribution of environmental 
factors. Therefore, their genomic information does not allow the 
military to make the reliable predictions necessary to protect its 
interests in minimizing health risks for service members and 
improving or maintaining military readiness.  
 
3 (2013); but see Noah Levin, A Defense of Genetic Discrimination, 
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65. GINA, supra note 61, at § 202(b). 
66. See Baruch & Hudson, supra note 6, at 439. 
67. See United States v. Windsor 133 S. Ct. 2675, 2695–96 (2013) (ruling 
that the federal government could not discriminate against state-
recognized same-sex marriages and, by extension, the individuals in such 
marriages); Bolling v. Sharpe 347 U.S. 497, 500 (1954) (extending the 
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While some of these arguments may be persuasive, particularly if 
they were made in a civilian context, it may be difficult to convince 
courts to restrict the military’s collection and use of genomic 
information. Traditionally, courts have been highly deferential to the 
military (a practice known as the military deference doctrine) 
regarding regulations and practices that may impinge on service 
member’s constitutional rights, but the military considers important 
for military readiness.68 This deference is generally based on three 
arguments:  
(1) military authorities are uniquely able to determine the 
unique needs of the armed forces in crafting military 
regulations; (2) courts are ill-equipped to determine the impact 
upon discipline that any particular intrusion upon military 
authority might have; and (3) military commanders have been 
charged by Congress and the President with carrying out the 
national military policy, and both of those branches have been 
conferred that power explicitly by the Constitution.69 
B. Invasion of Privacy: Lessons from DoD DNA Registry 
If the military established a PGS program, service members could 
also argue that the collection and analysis of their genomic 
information constitutes a violation of their privacy rights. In order to 
evaluate this claim it is important to consider relevant precedents. In 
1991 DoD initiated a DNA Registry to collect and store blood and 
saliva samples from all service members for the purposes of remains 
identification.70 Soon after the program began, two servicemen refused 
 
68. See generally John F. O’Connor, The Origins and Application of the 
Military Deference Doctrine, 35 GA. L. REV. 161 (2000) (characterizing 
the Supreme Court’s traditional military deference as rooted in a 
reading of the Constitution that allowed the military to act as needed 
under the president’s Art. II authority as commander-in-chief of the 
military); see generally Steven B. Lichtman, The Justices and the 
Generals: A Critical Examination of the U.S. Supreme Court’s 
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to provide specimen samples for the DNA Registry and challenged the 
constitutionality of the program.71 While the district court’s decision 
was eventually vacated as moot because the servicemen were 
honorably separated from active duty, the plaintiffs’ arguments are 
illustrative of the kinds of challenges a more comprehensive genomic 
sequencing program could face if implemented in the military.  
The servicemen’s strongest argument in Mayfield v. Dalton was 
that the specimen collection constituted an unreasonable seizure for 
the purposes of the Fourth Amendment.72 However, the court held 
that the collection of specimens “for the military’s DNA registry, 
though undoubtedly a “seizure,” is not an unreasonable seizure and is 
thus not prohibited by the Constitution.”73 The court favorably cited 
cases noting that military personnel have a diminished expectation of 
privacy; found that specimen collection is a relatively limited 
invasion; and considered that the restricted purpose of the program 
(i.e. remains identification), and the compelling interest protected (in 
the instance of remains identification, “confirm which of its members 
has fallen in battle[,] . . . may have been taken prisoner or are 
otherwise unaccounted for [and being able to provide] solace [to the 
relatives of fallen servicemen, via the] speedy and definite 
identification of the remains of their loved ones”74) make the specimen 
collection a reasonable seizure under the Fourth Amendment. 75  
Interestingly, one of the plaintiffs’ claims in Mayfield was that the 
military could expand its use of the specimens collected. They argued 
that at some point the military could “use the DNA samples for some 
less innocuous purpose, such as the diagnosis of hereditary diseases or 
disorders.”76 The court found that the plaintiffs presented no evidence 
that the military had used or planned to use the samples for any 
purpose other than remains identification, thus “[a] challenge to such 
hypothetical future use, or misuse . . . does not present a justiciable 
case or controversy.” 77  
C. Unreasonable Seizure of Genomic Information 
Twenty years after the plaintiffs in Mayfield raised concerns about 
other potential uses of genetic information, military advisors, such as 
the authors of the JASON Report, are discussing the possibility that 
 
71. Mayfield, 901 F. Supp. 300, vacated as moot, 109 F. 3d 1423 (9th Cir. 
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the DoD might establish a genomic sequencing program, which could 
potentially be used for predicting a service member’s risk for 
developing PTSD. This type of program would be more challenging 
from a Fourth Amendment standpoint because it could be argued 
that the broader kind of information sought and the multiple 
potential uses of this information would make the unconsented seizure 
of a blood or saliva sample for the genomic sequencing program 
unreasonable. As with DoD’s DNA Registry, the PTSD-PGS would 
involve the collection of blood or saliva samples, thus in this sense the 
physical intrusion upon service members would not be any worse than 
what the DNA Registry program requires. However, in this nascent 
era of genomics, limiting any Fourth Amendment analysis that 
involves genetic or genomic testing to whether the collection of blood 
or saliva is a reasonable seizure given the government’s interests, 
would completely ignore the core issue that is really at stake: the 
seizure of genomic information.  
What would make the collection of samples for the PTSD-PGS 
program more invasive than the DNA Registry—and perhaps 
unreasonable in terms of the Fourth Amendment—is the kind of 
information extracted from these blood or saliva samples and how the 
military is expected to use that information. PTSD-PGS would likely 
employ WGS or WES, meaning that DoD would collect DNA 
sequencing data from the entire genome (WGS) or all-protein coding 
genes in the genome (WES). Either way, the raw DNA data collected 
by WGS or WES would be much broader than the genetic 
information extracted from blood or saliva samples for the purposes of 
remains identification. WGS or WES data would allow the military to 
determine all of a service member’s medical genomic risks known in 
the scientific literature, including risks and predispositions that are 
unrelated to his or her fitness for military duty.   
Furthermore, the purpose of the PTSD-PGS program would be to 
determine health risks and the likelihood of phenotypes and traits 
relevant for military duties in order to decide whether a service 
member is fit for duty or at least how equipped the service member 
may be for particular assignments from a genomic standpoint.78 This 
information would have much broader implications for a service 
member’s entire military career than the identification of his or her 
remains. The information could be used to determine assignments, 
which could limit the ways in which service members could serve, and 
negatively impact their opportunities for getting promotions and 
advancing their military careers.  
On the other hand, regardless of how invasive WGS/WES may 
be, the military can argue that it has some very compelling interests 
to protect with PSTD-PGS, primarily concerning the health and well 
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being of service members, and military readiness. These compelling 
interests, combined with the military deference doctrine, may mean 
that in practice the only viable option for service members looking to 
significantly limit the scope of a military genomic sequencing program 
and the way this information is used would not be through the courts. 
Rather, they may need to convince Congress to regulate the collection 
and use of genomic information in the military.79 
D. Unreasonable Search of Genomic Information  
Interestingly, even if courts held that the seizure of samples for a 
military genomic sequencing program was reasonable, service 
members may be able to argue that certain searches within their 
genome would be unreasonable. For instance, service members could 
argue that the genomic information sought and analyzed by a 
military’s WGS/WES program should be limited to sequencing 
information directly related to military readiness or the minimization 
of health risks that may be prompted or exacerbated by military 
duty. Even when WGS or WES is performed, laboratories have the 
bioinformatics capacity to determine which genes are analyzed and 
interpreted in order to determine specific health risks. Therefore, it is 
possible to restrict the information sought and analyzed by the 
military to that relevant to military duty and readiness. One problem 
with this could be finding an adequate way to define which genomic 
information is sufficiently related to military readiness. If defined too 
broadly, it may intrude into elements of the service member’s health 
that have little bearing on their ability to perform their mission. 
However, it seems like the search and analysis of genes such as those 
closely associated with colon cancer (e.g. MLH1, MSH2, MSH6, and 
PMS2) or hereditary breast and ovarian cancer (e.g. BRCA 1 and 
BRCA 2) could be considered an unreasonable invasion of service 
members’ intimacy unless consented.   
V. Ethical Challenges 
The prospect of a PTSD-PGS program also raises a range of 
ethical and social challenges that will require consideration by DoD, if 
the agency is to comply with the JASON Report’s prescriptions for 
military genomics. These range from questions about the impact of 
implementing such a program on the units to which individual service 
people belong, to issues at the interfaces of the military with civilian 
society, to challenges in the design and implementation of the 
research necessary to develop evidence-based PGS programs in the 
first place. 
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A. Unit Cohesion and Fair Distribution of Combat Risk 
One of the interesting features of the military is that it is one of 
the few American social spheres where the rights and interests of the 
individual do not come first. As William Rhodes articulates in his 
introduction to military ethics:  
As a result, militaries put tremendous emphasis on an ethical 
requirement to value the needs of one’s group above personal 
desires. Sometimes this is referred to, as in military “core 
values” statements, as the virtue of selflessness. In its highest 
manifestation, an individual’s identification with his unit is so 
thoroughgoing that he sees little distinction between the unit’s 
well-being and his own . . . . Fear of failing one’s subordinates 
or failing to accomplish the mission that others are depending 
on become predominant ethical worries.80 
On one hand, this means that many of the usual autonomy-based 
bioethical worries over preventive genomic sequencing (the need for 
adequate individual informed consent to sequencing, rights to know or 
not know sequencing results and incidental findings, the privacy of 
these findings, etc.) are, if not moot in the active duty context, at 
least relocated from individuals to the commanders responsible for 
their best interests. If the chain of command concurs that the privacy 
costs and discrimination risks of PGS are proportionate to the 
mission-oriented benefits that relevant military cohorts could garner, 
our civilian fixation on personal freedoms of opportunity and self-
determination would not stand in the way.   
On the other hand, as Rhodes stresses, privileging the interests of 
the cohort over the individual also generates a commitment, on the 
part of both commanders and subordinates, to the cohesion of the 
unit and a mutuality of effort within it. Teamwork is prized and its 
opposite is castigated as “shirking”:  contriving to relieve oneself of 
duty to avoid one’s group obligations. As sympathetic as Corporal 
Klinger’s cross-dressing efforts gain a psychiatric  “Section 8” 
discharge from his M.A.S.H. duties were for his American TV 
audience in the 1970’s, he was not behaving like a good soldier. 
Moreover, his vice was not cowardice:  it was that his group needed 
him to fulfill their mission, which would suffer from his departure.   
In this context, a commander contemplating a PTSD-PGS in an 
otherwise asymptomatic cohort faces an ethical challenge:  would it be 
fair to the unit to reassign soldiers to noncombat roles on the basis of 
probabilistic, but unproven, risk of downstream PTSD? First of all, if 
genetic markers for PTSD risk are as common in the population as 
the incidence of the disorder suggests, this could itself have a 
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destabilizing effect on the unit as whole. Should all cases of PTSD 
risk be treated alike for reassignment purposes, or could key personnel 
– e.g. the Tank Commander, the Demolitions Expert, the IT Expert-- 
be kept in their combat roles on other grounds of military necessity 
regardless of their genomic status? These decisions are exacerbated, 
secondly, by the fact that the benefits of PTSD-PGS to any particular 
cohort or unit are never going to be directly mission-related. To the 
extent that PTSD is a most often a delayed onset condition, a 
preventive screening program may be in at-risk individuals’ eventual 
health interests, and could certainly benefit the military veterans 
health care system by saving downstream costs. But it is not clear 
how it can help a unit meet its primary military objectives. In fact, 
since the ordinary and expected risks of combat are more severe and 
predictable than a genomic risk of PTSD, a program that allows (or 
forces) soldiers to avoid the former in the name of avoiding the latter 
may look more like a shirkers’ lottery than a humane service, at least 
to those left to face the trial of combat.  In sum, by disrupting unit 
cohesion and relieving asymptomatic soldiers of their ordinary risk-
taking obligations, such a program may appear to commanders like a 
disproportionate risk to their unit’s functionality, even if its risks to 
its individual recipients are negligible. If commanders are to take the 
morale and mission-readiness of their units as their primary concern, 
this may simply relocate what might be considered “autonomy-based” 
ethical challenges to mounting universal PTSD-PGS upwards within 
chains of command as issues of professional integrity for unit 
commanders.81 
B. During Active Duty, Training, or Recruitment? 
Perhaps the foregoing concerns indicate that active duty 
personnel who already belong to mission-oriented military units are 
simply the wrong target for PTSD-PGS. If PTSD risk information 
was collected and used earlier in a service person’s military life, 
during training, for example, units themselves could be composed of 
either high and low risk personnel from the start, depending on their 
missions, in the way that aptitude tests are already used to assign 
new recruits to different kinds of military vocations. Or, to take a 
step further back, why not employ the PGS during recruitment, to 
pursue a “PTSD-free” military across the board?    
Conducting PTSD-PGS during military training has attractions 
similar to newborn genetic screening in the public health context.82 
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Detected early enough, the long-term harms of a recruit’s genomic 
vulnerabilities could be taken into account even in developing their 
military life-plan, by putting them on a low-stress diet of stateside 
desk jobs and support missions that would avoid the environmental 
triggers of their (possible) predisposition. This approach would take 
the program’s risk/benefit calculations out of the (benignly 
paternalistic) hands of unit commanders, avoid the unit cohesion and 
shirking issues, and make it easier to justify implementing PTSD-PGS 
universally across the military, rather than just for those most likely 
to encounter the environmental triggers of PTSD.  
On the other hand, this would create a bifurcated military, with a 
class of behind-the-lines support units composed heavily of PTSD-
vulnerable recruits, and a combat class composed of recruits of 
unknown PTSD risks. In the hierarchical and specialized world of the 
military, this bifurcation in itself may be no cause for moral alarm. 
But it could run afoul of two important military moral values that 
would make it problematic. The first is the principle of military 
advancement through merit.83 If one’s genomic classification places a 
permanent bar on certain military career paths, it compromises the 
ability of service people to “work themselves up from the ranks” to 
leadership positions. The perception that the military embraces and 
empowers personal initiative by its members to overcome their own 
limitations, and “be all they can be” despite the vagaries of their 
social backgrounds is important both to its members sense of 
solidarity and its external recruitment efforts. Mandatory genomic 
sorting could damage that perception on both fronts, especially if 
people thought that only those on the “high stress track” would have 
important opportunities to demonstrate military virtues like courage, 
self-sacrifice, leadership and strength, in ways that count as military 
heroism.84 This risk, in turn, reflects the other value at stake:  the 
opportunity that the military offers recruits to leave the unjust 
prejudices of civilian society behind, in favor of a system without 
systematically favored groups defined on mission-irrelevant grounds. 
The military’s internal sense of fairness demands that no one should 
be denied the opportunity to prove themselves if they can “pass 
muster” for the job at hand, regardless of their biological 
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background.85 Doing so on the basis of their genomic foreground, the 
argument would go, seems just as discriminatory.   
One possible way out of these conundrums is suggested by the 
newborn screening analogy. For the case of phenylketonuria risk 
screening in newborns, at least, the idea is to follow the early 
detection of PKU risk with a special diet designed to protect the 
patient’s brain from a poisonous accumulation of phenylketones 
during its postnatal development, after which a normal diet can be 
resumed. If a sequence-informed service assignment were not 
permanent, but capable of being “tested out of” by doing well with 
regimen of hypothetical PTSD “challenges,” perhaps its threat to the 
military’s meritocractic ethos could be avoided. But even such a 
regimen of special vetting could endanger another important military 
ethical commitment if it came to reflect negatively on “low stress” 
service careers themselves.   
A corollary of the military values of opportunity and fairness is 
that, in (military ethical) theory, low stress but critical military 
support operations should enjoy the same prestige as combat units, 
and afford equally honorable opportunities for leadership and 
heroism.86 Given the military’s veneration of warrior heroes, it is a 
continuing psychosocial challenge to inculcate and promote this 
principle of equity, both within military circles and in the wider 
society. It would undermine that effort if a genomic sorting program 
early in a military career carried a perceived stain of weakness to 
those in non-combatant military career paths. But unlike other 
disabilities, such as an amputation, or even other genetic 
vulnerabilities, like Long Q-T syndrome, PTSD is about a soldier’s 
resilience in the face of the kinds of trauma strong soldiers are 
expected to face. It has a direct connection to core mission-related 
military virtues that makes it particularly potent as a vulnerability 
and stigmatizing to the service assignments with which it becomes 
associated.  
One way to try to avoid all these worries would be to use PGS 
even earlier during recruitment, to help build a military that has as 
few personnel at high risk for PTSD as possible. If targeting PTSD-
PGS to trainees is like newborn screening, this approach could be 
analogized to prenatal screening:  its goal would be to select out only 
those recruits who do not show the PTSD markers, and reject those 
who do from military service altogether, in a genomic version of the 
old 4F exclusion.   
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As appealing as this approach appears from inside the military, 
however, it does face significant social challenges. Now we are in the 
situation of performing genomic sequencing on individuals who are 
not yet part of the military and still retain their full panoply of 
autonomy rights. Even if the armed services could, in the face of the 
ADA and the Equal Protection clause, legally make the absence of 
genomic markers for PTSD risk a prerequisite for recruitment into 
military employment, the moral case for genetic discrimination 
against would-be volunteers who carry the risk markers would be 
strong, given the many military occupations in which such recruits 
could excel without risk to the military’s mission. Moreover, in 
performing PTSD-PGS on civilians, recruiters would face all the 
challenges now being encountered in clinical and public health 
settings in which WGS/WES is being implemented.87 Fully informed 
consent to the sequencing would be morally required, including 
disclosures concerning the psychosocial risks as well as the benefits of 
identifying PTSD markers and other genomic information that may 
be examined. Plans for managing incidental and secondary target 
findings, especially medically actionable findings, would need to be in 
place. Questions about the storage and disposition of their sequence 
data would need to be addressed, especially for those who are rejected 
or decline to join the military for other reasons. Would their data be 
expunged, or placed under their control in some other way? What 
privacy protections would it enjoy during its analysis and use by the 
military recruiters? Those who currently aspire to use sequencing 
technologies in civilian clinical and public health settings are already 
besieged by the complexity of these challenges. If the attempt to 
manage them for the purposes of military recruitment simply 
compounds the public relations challenge of proposing to use genomic 
screening to insure a military without PTSD, the whole approach 
begins to look doubtful.  
C. Genetic Essentialism and Post-Service Stigmatization 
The problem with using PTSD-PGS as a recruitment screen is 
that it has to happen at the interface of the civilian and military 
moral spheres, where civilian values still have purchase. Another set 
of related issues arise at the other end of a military career, after a 
discharge from the armed services. As the VA exemplifies, the 
military’s ethical obligations to its personnel extend well beyond their 
active service. Conscientious military planners will have to consider 
the implications of PTSD-PGS for veterans in their post-military 
civilian lives. If carrying PTSD risk markers is a serious enough 
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vulnerability to warrant exclusion from core military assignments—or, 
more crucially, from military service itself—what should civilian 
institutions make of that fact when assessing the merits of veteran 
applicants for high stress positions? In civilian life, the prudential 
over-determinism of PTSD-PGS could easily be misinterpreted as a 
strong genetic essentialism, allowing all the individual’s qualities to be 
eclipsed by their genomic markers in a scientifically inappropriate 
overinterpretation of their significance in civilian life. Even if the 
applicants’ individual genomic marker results are undisclosed, a 
military record of low stress assignments, or a genomic 4F designation 
could come to exacerbate the social burden that veterans already face 
when they are stigmatized as “unstable” or unreliable under stress. 88 
The military could join other efforts within the genomics community 
to demythologize genomic information though public education, but it 
would have to face the challenge that the humbler interpretations of 
PTSD genomics required to counteract those invidious 
misinterpretations will also cut against the rationale for conducting 
PTSD-PGS for personnel assignments in the first place.  
D. Research Ethics Issues 
Finally, how should a PTSD-PGS program be developed and 
tested? To be ethically justified, it would have to be well grounded in 
the best evidence available that its candidate markers were robust 
predictors of PTSD risk, that assigning high risk personnel to low 
stress roles would reduce that risk, and that the psychosocial sequelae 
of being labeled at high PTSD risk—both during active duty and 
after discharge—do not outweigh its benefits.89 Unlike 
pharmacogenomic trials involving clear physiological pathways and 
discrete outcomes, it is almost impossible to imagine a controlled, 
scientifically rigorous study that could produce this evidence without 
amounting to the widespread implementation of the program and its 
longitudinal follow-up.   Biomedical research with service personnel is 
sometimes excused from the usual requirements of voluntary informed 
consent, free withdrawal, and confidentiality out of military necessity, 
but usually in the face of some imminent threat to an overriding 
military mission objective. Would the prevention of PTSD in veterans 
and the accompanying health care cost savings merit such an 
exemption?90 If not, the program’s (large) exploratory phase would 
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have to be accompanied, like other military health services research, 
with a version of the usual protections for human research 
participants in place. 91 That would, again, bring the military back to 
many of the same ethical challenges that genomic sequencing research 
is currently facing in other clinical and public health settings. 
VI. Conclusions 
Despite current scientific enthusiasm over preventive genomic 
sequencing, the deference of American law to military necessity, and 
the unique features of military morality, the prospect of a military 
PTSD-PGS program may be more challenging than the JASON 
Report suggests. In fact, the three sections of this tour of the 
scientific, legal and ethical considerations involved in mounting such a 
program come together to effectively dissolve the rationales that 
might have insulated a military program from the complexities of the 
ongoing debates over PGS in our individualistic civilian context, in 
four ways.  
First, it is clear that the state of PTSD genomics is far from being 
robust enough to support a meaningful PGS program. Under that 
scientific uncertainty, commanders will not have the evidence they 
need to make responsible decisions about their subordinates’ best 
interests in this context, given the possible harms of PTSD risk 
labeling in both active duty and post-discharge settings. Since it is 
unlikely that any individual’s downstream risks for PTSD will 
jeopardize a unit’s immediate functionality except through the 
destabilizing effects of reassignment, commanders who are given a 
choice are likely to forego the program for those under their 
command, despite the risk of increased costs to the military health 
care system. If commanders are not given a choice but are unable to 
endorse the program, military ethics prescribes that they share their 
inability with their troops and relinquish their paternalistic authority 
by calling for volunteers.  
Second, while legal doctrine might support the military’s 
authority to create a PTSD-PGS program, such a program’s 
interfaces with the civilian lives of either new recruits or discharged 
veterans reintroduce legal and civil rights challenges that strictly 
internal military interventions can avoid. If PTSD-PGS is used as a 
recruiting screen, it faces both constitutional challenges and the 
ethical complexities of civilian genomic sequencing. If it is limited to 
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active duty personnel, its planners must develop ways to mitigate the 
potentially adverse impact of PTSD risk labeling on veterans 
opportunities and the lives of their families.  
Third, the practice of segregating personnel with high genomic 
PTSD risk into low stress assignments may run afoul of the military’s 
own ethical commitment to a level playing field for meritocratic 
advancement, and its disinterest in stigmatizing critical non-combat 
vocations. As a result, even the military’s internal morality may push 
planners to make room for informed choices by volunteers who are 
willing, like the ship’s cook manning the anti-aircraft gun at Pearl 
Harbor, to take on additional PTSD risks in their unit’s interest.  
Fourth, since PTSD-PGS does not address any imminent military 
necessity beyond the long-term health and health care costs of 
individual personnel, its development should be governed by the 
research ethics that regulates other health service research in the 
military. If PTSD-PGS is to eventually gain the evidence base it will 
require to be ethically justifiable as a universal military program, it 
will require testing in longitudinal cohort studies that will have to 
offer their participating personnel the standard autonomy-oriented 
protections.  
Discussions of workplace genetic screening in the 1980’s often 
ended with a recommendation that represented a compromise between 
those who would use genetic testing to involuntarily exclude the 
hypersusceptible from occupational exposures to toxins and those who 
criticized such proposals as paternalistic and potentially 
discriminatory. 92 The compromise was to have companies offer the 
genetic testing as a health service to their workers, and to allow 
individual employees to decide whether or not to avail themselves of 
the service or follow up on its findings. While some declined such 
services, those that used them and discovered themselves to be 
hypersusceptible to the workplace toxins overwhelmingly took 
voluntary steps to minimize their risks. It may be that this is where 
the challenges in PTSD-PGS in the military are pointing as well. 
From the legal and ethical perspectives the least problematic way of 
establishing an PTSD-PGS program for military personnel may be to 
make it a voluntary program for service members and to offer 
targeted sequencing of those loci that are known to be most relevant 
to the phenotypes most closely associated with a given individual’s 
military duties. Under this personalized approach to PTSD-PGS, 
individual service members would decide whether to learn their own 
risk status as a matter of personal health planning beyond their 
military responsibilities rather than as a matter of professional 
military duty. Those that learned they were at increased genomic risk 
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for PTSD could be given the opportunity to decide whether they 
want to report this information in order to request reasonable 
accommodation, similar to the way the American’s with Disabilities 
Act works in civilian contexts. This degree of autonomy may be at 
odds with military tradition. But, the probabilistic information that 
PTSD-PGS will be able to provide for the foreseeable future is so 
uncertain, can have such profound implications for service members’ 
social success within and beyond the military, and could be 
misinterpreted and misused in so many ways detrimental to military 
values, that repositioning PGS as an optional perk of military service, 
like subsidized PX prices or the G.I. Bill, rather than using it as a 
weapon, an element of a new genomic arms race, may be the better 
part of valor. 
  
